These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15171662)

  • 21. Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy.
    Colonna C; Conti B; Perugini P; Pavanetto F; Modena T; Dorati R; Iadarola P; Genta I
    Eur J Pharm Biopharm; 2008 Sep; 70(1):58-65. PubMed ID: 18547793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibition of A549 cells by polybutylcyanoacrylate nanoparticles loaded with antisense oligodeoxynucleotide of hTERT mRNA].
    Zhang YY; Fu CJ; Zhang ZZ
    Yao Xue Xue Bao; 2006 May; 41(5):446-51. PubMed ID: 16848322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
    Yang XR; Zong L; Yuan XY
    Yao Xue Xue Bao; 2007 Jul; 42(7):774-9. PubMed ID: 17882964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
    Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
    J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
    Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY
    Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
    Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
    Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells.
    Mi FL; Wu YY; Chiu YL; Chen MC; Sung HW; Yu SH; Shyu SS; Huang MF
    Biomacromolecules; 2007 Mar; 8(3):892-8. PubMed ID: 17316043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
    Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan.
    Sheng Y; Liu C; Yuan Y; Tao X; Yang F; Shan X; Zhou H; Xu F
    Biomaterials; 2009 Apr; 30(12):2340-8. PubMed ID: 19150737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW; Wang SS; Tsai WJ
    Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of folate-chitosan-DNA nanoparticles for gene therapy.
    Mansouri S; Cuie Y; Winnik F; Shi Q; Lavigne P; Benderdour M; Beaumont E; Fernandes JC
    Biomaterials; 2006 Mar; 27(9):2060-5. PubMed ID: 16202449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan.
    Chiu YL; Ho YC; Chen YM; Peng SF; Ke CJ; Chen KJ; Mi FL; Sung HW
    J Control Release; 2010 Aug; 146(1):152-9. PubMed ID: 20580915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.
    Grenha A; Grainger CI; Dailey LA; Seijo B; Martin GP; Remuñán-López C; Forbes B
    Eur J Pharm Sci; 2007 Jun; 31(2):73-84. PubMed ID: 17408932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.
    Taetz S; Nafee N; Beisner J; Piotrowska K; Baldes C; Mürdter TE; Huwer H; Schneider M; Schaefer UF; Klotz U; Lehr CM
    Eur J Pharm Biopharm; 2009 Jun; 72(2):358-69. PubMed ID: 18703137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
    Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
    Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles attenuate P-glycoprotein/MDR1 function in A549 human alveolar epithelial cells.
    Salomon JJ; Ehrhardt C
    Eur J Pharm Biopharm; 2011 Apr; 77(3):392-7. PubMed ID: 21093586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Free amino groups on the surface of chitosan nanoparticles and its characteristics].
    Lin AH; Liu YM; Ping QN
    Yao Xue Xue Bao; 2007 Mar; 42(3):323-8. PubMed ID: 17520835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.